drugset
drugset / Trial / NCT01413893

An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid Tumors

NCT01413893 ↗

Phase 1 Completed 35 enrolled AbbVie
Non-randomizedSingle-groupOpen-labelBasic science

Summary

An extension study of linifanib in subjects with advanced or metastatic solid tumors.

Timeline

Start
2011-06
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject ABT-869 Unknown — —

Indications

cancer